DNAnexus is the global standard for omics intelligence. Founded in 2009 with a singular commitment to omics, DNAnexus has become the trusted foundation where the world’s omics data and AI converge to advance human health, enabling our customers and partners to turn the most complex data in healthcare into faster discoveries, better outcomes and, ultimately, cures. Pharma companies, diagnostic laboratories, health systems, biobanks, and government agencies use DNAnexus to decode fragmented omics into standardized, AI-ready data; to discover new therapies, from target and biomarker discovery to population-scale research; and to deliver those discoveries into regulated, real-world impact. DNAnexus enables scientists, models, and agents to work on the same governed, AI-ready data. Today DNAnexus serves the largest globally connected community of scientists and researchers. More than 64,000 users across 54 countries and 130+ enterprise customers run regulatory-grade omics work on DNAnexus, including the FDA’s precisionFDA and the UK Biobank Research Analysis Platform, across more than 140 petabytes of omics and clinical data. Let’s create a world where omics and AI, working as one, give everyone longer, healthier lives. Learn more at dnanexus.com.
Looking for a particular DNAnexus employee's phone or email?
The DNAnexus annual revenue was $32.4 million in 2026.
Thomas Laur is the CEO of DNAnexus.
224 people are employed at DNAnexus.
DNAnexus is based in Mountain View, California.
The NAICS codes for DNAnexus are [541, 54, 541713, 54171, 5417].
The SIC codes for DNAnexus are [73, 737, 7379, 7374].